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ABSTRACT The most well-established structural feature of amyloid ﬁbrils is the cross-b motif, an extended b-sheet structure
formed by b-strands oriented perpendicular to the long ﬁbril axis. Direct experimental identiﬁcation of non-b-strand
conformations in amyloid ﬁbrils has not been reported previously. Here we report the results of solid-state NMR measurements
on amyloid ﬁbrils formed by the 40-residue b-amyloid peptide associated with Alzheimer’s disease (Ab1-40), prepared
synthetically with pairs of 13C labels at consecutive backbone carbonyl sites. The measurements probe the peptide backbone
conformation in residues 24-30, a segment where a non-b-strand conformation has been suggested by earlier sequence
analysis, cross-linking experiments, and molecular modeling. Data obtained with the fpRFDR-CT, DQCSA, and 2D MAS
exchange solid-state NMR techniques, which provide independent constraints on the f and c backbone torsion angles between
the labeled carbonyl sites, indicate non-b-strand conformations at G25, S26, and G29. These results represent the ﬁrst site-
speciﬁc identiﬁcation and characterization of non-b-strand peptide conformations in an amyloid ﬁbril.
INTRODUCTION
Amyloid ﬁbrils are ﬁlamentous structures, with typical
diameters of roughly 5–20 nm and lengths up to several
microns, formed by numerous peptides and proteins with
disparate sequences and molecular weights (Sunde and
Blake, 1998). Current interest in amyloid ﬁbrils arises from
their occurrence in amyloid diseases (Sipe, 1992), including
Alzheimer’s disease, type-2 diabetes, Parkinson’s disease,
Huntington’s disease, and prion diseases, and from funda-
mental questions regarding the molecular mechanism of
amyloid formation and the nature of the intermolecular
interactions that make the amyloid ﬁbril a stable form for an
extremely diverse class of polypeptides (Chiti et al., 1999;
MacPhee and Dobson, 2000). Amyloid ﬁbrils share certain
deﬁning properties, including an unbranched morphology in
electron microscope (EM) images, pronounced and typically
green optical birefringence after Congo Red staining, and an
x-ray scattering pattern indicative of a ‘‘cross-b’’ structure,
i.e., an extended b-sheet structure formed by intermolecular
hydrogen bonding in which the b-strand segments run
approximately perpendicular to and the hydrogen bonds
run approximately parallel to the long axis of the ﬁbril.
Deﬁnitive evidence for the cross-b structure comes from
x-ray diffraction studies (Kirschner et al., 1987; Inouye et al.,
1993; Sunde et al., 1997) and more recently from EM
(Serpell and Smith, 2000).
More detailed and site-speciﬁc structural information has
been difﬁcult to obtain in amyloid ﬁbrils because of their
inherently noncrystalline and insoluble nature. Recently,
several groups have used solid-state NMR techniques to
characterize the supramolecular organization of the b-sheets
in amyloid ﬁbrils, especially ﬁbrils formed by the b-amyloid
(Ab) peptide associated with Alzheimer’s disease (Antzutkin
et al., 2000; Antzutkin et al., 2002; Balbach et al., 2002;
Petkova et al., 2002) and several Ab fragments that serve as
important model systems (Lansbury et al., 1995; Benzinger
et al., 1998; Gregory et al., 1998; Balbach et al., 2000;
Benzinger et al., 2000; Burkoth et al., 2000). One un-
anticipated result from solid-state NMR spectroscopy is that
the b-sheets in full-length Ab ﬁbrils and in certain Ab
fragment ﬁbrils have a parallel, in-register structure (Ben-
zinger et al., 1998; Gregory et al., 1998; Antzutkin et al.,
2000; Benzinger et al., 2000; Burkoth et al., 2000; Antzutkin
et al., 2002; Balbach et al., 2002), whereas the b-sheets in
other Ab fragment ﬁbrils have antiparallel structures (Lans-
bury et al., 1995; Balbach et al., 2000). Linewidths in solid-
state NMR spectra of amyloid ﬁbrils indicate a high degree
of structural order in certain segments of the peptide
sequence (Balbach et al., 2000; Ishii, 2001; Petkova et al.,
2002). In the case of full-length Ab ﬁbrils, NMR linewidths
and intermolecular dipole-dipole couplings indicate a disor-
dered N-terminal segment of ;10 residues (Balbach et al.,
2002; Petkova et al., 2002), consistent with proteolysis data
(Roher et al., 1993; Saido et al., 1996; Kheterpal et al.,
2001). 13C NMR chemical shifts have been used to identify
speciﬁc peptide segments that form b-strands in amyloid
ﬁbrils (Balbach et al., 2000; Ishii, 2001; Laws et al., 2001;
Petkova et al., 2002).
Although the cross-b structure is the predominant
structural motif in amyloid ﬁbrils, the dimensions of Ab
ﬁbrils suggest that the full-length peptide (Ab1-40, 40
residues; Ab1-42, 42 residues) adopts a structure that includes
non-b-strand conformations. The thinnest Ab1-40 and Ab1-42
ﬁbrils observed in EM images have diameters of 6 6 1 nm
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(Goldsbury et al., 2000; Antzutkin et al., 2002; Petkova et al.,
2002). The length of a b-strand formed by M residues is
approximately M 3 0.34 nm. Given a 10-residue disordered
N-terminal segment, a minimum diameter of 10 nm would be
expected for Ab1-40 and Ab1-42 ﬁbrils if the remainder of
the peptide formed a single, continuous b-strand. Circular
dichroism spectra and secondary structure predictions based
on the Ab amino acid sequence (Kirschner et al., 1987;
Hilbich et al., 1991) have suggested a b-turn in residues 23-
30 (sequence DVGSNKGA). A b-turn (Lazo and Downing,
1998; George and Howlett, 1999; Li et al., 1999) or other
non-b-strand conformation (Tjernberg et al., 1999) in this
segment has been incorporated into several structural
models. Measurements of enzymatic N-terminal proteolysis
of Ab10-43 analogs with intramolecular disulﬁde linkages
have been described as experimental support for a b-turn
encompassing residues 26-29 (Hilbich et al., 1991).
In this paper, we report solid-state NMR data that
demonstrate a non-b-strand conformation in residues 24-30
of Ab1-40 ﬁbrils and permit estimation of the f and c torsion
angles, which deﬁne the peptide backbone conformation,
at speciﬁc sites in this segment. The measurements were
carried out on a series of samples in which pairs of 13C labels
were introduced at consecutive backbone carbonyl sites.
Three solid-state NMR techniques that place independent
constraints on the f and c values between the two 13C labels
were employed, namely constant-time ﬁnite-pulse radio-
frequency-driven recoupling (fpRFDR-CT) (Ishii et al.,
2001), double-quantum chemical shift anistropy (DQCSA)
spectroscopy (Blanco and Tycko, 2001), and two-dimen-
sional magic-angle spinning (2D MAS) exchange spectros-
copy (Tycko et al., 1996; Weliky and Tycko, 1996; Tycko
and Berger, 1999). These techniques have previously been
demonstrated on model compounds and applied in structural
studies of a variety of peptides and proteins, including
amyloid ﬁbrils (Long and Tycko, 1998; Weliky et al., 1999;
Balbach et al., 2000; Blanco et al., 2001; Antzutkin et al.,
2002; Balbach et al., 2002). The results in this paper
represent the ﬁrst site-speciﬁc characterization of non-b-
sheet structure in an amyloid ﬁbril.
MATERIALS AND METHODS
Peptide synthesis, puriﬁcation, and ﬁbrillization
Peptides with the human Ab1-40 sequence DAEFRHDSGYEVHHQKLVF-
FAEDVGSNKGAIIGLMVGGVV were synthesized on an Applied Bio-
systems (Foster City, CA) Model 433A automated solid-phase peptide
synthesizer, cleaved from the synthesis resin, and puriﬁed by high-
performance liquid chromatography as previously described (Antzutkin
et al., 2000; Balbach et al., 2002). Ab1-40 was ﬁbrillized by dissolution in
deionized water at ;1 mM concentration (estimated from lyophilized
peptide weight), adjustment to pH 7.4 by dropwise addition of dilute NaOH
(from an initial pH  3.3), addition of 0.01% NaN3, and incubation at room
temperature with gentle rocking for 10–20 days. Solutions typically became
noticeably viscous after several hours and gelled within several days.
Incubated solutions were lyophilized for solid-state NMR measurements.
The extent of ﬁbrillization was assessed by one-dimensional (1D) 13C NMR
spectroscopy (see below). Samples found to be incompletely ﬁbrillized were
reincubated for an additional 10–20 days. Typical solid-state NMR samples
were 10 mg.
Samples were prepared with 13C labels at the backbone carbonyl sites of
D23 and V24 (D23,V24-Ab1-40), V24 and G25 (V24,G25-Ab1-40), G25 and
S26 (G25,S26-Ab1-40), K28 and G29 (K28,G29-Ab1-40), and G29 and A30
(sample G29,A30-Ab1-40). Amino acids with carboxyl
13C labels were
purchased from Cambridge Isotopes Laboratories (Cambridge, MA) and
Isotec (Miamisburg, OH) either with protecting groups required for peptide
synthesis or as the bare amino acids. Fluorenylmethoxycarbonyl (FMOC)
and side-chain protection reactions were performed by Midwest Biotech
(Fishers, Indiana) when required. Because 13C-labeled asparagine could not
be obtained, samples labeled at the backbone carbonyl site of N27 could not
be prepared.
Protection of 13C-labeled aspartate, performed by Midwest Biotech,
resulted in a mixture of the desired product (N-a-FMOC-L-aspartic acid b-t-
butyl ester) and an undesired isomer (N-a-FMOC-L-aspartic acid a-t-butyl
ester) that incorporates into the peptide as b-aspartate with a 13C-labeled
side chain. The undesired isomer was present at a level of ;20% in
D23,V24-Ab1-40 after puriﬁcation, based on
13C NMR (Fig. 1). Although
substitution of b-aspartate for aspartate may introduce a local structural
perturbation in peptide chains containing the undesired isomer in the
D23,V24-Ab1-40 sample, peptide chains containing this isomeric sub-
stitution did not contribute signiﬁcantly to the fpRFDR-CT, DQCSA, and
2D MAS exchange measurements (because of the larger intramolecular
13C-13C distance and because of resolvable chemical shift differences) and
hence did not affect any conclusions in this study regarding the con-
formation of Ab1-40 in amyloid ﬁbrils. We emphasize that this impurity was
present only in the D23,V24-Ab1-40 sample, and that data for this sample are
not the basis for our report of non-b-strand conformations in Ab1-40 ﬁbrils
(see below).
Solid-state NMR measurements
1D 13C NMR spectra were obtained with cross-polarization, magic-angle
spinning (MAS), and high-power proton decoupling, using a Varian (Palo
Alto, CA) Chemagnetics Inﬁnity spectrometer operating at a proton NMR
frequency of 599.1 MHz and a homebuilt probe with a 2.5-mm Varian/
Chemagnetics MAS module. Cross-polarization contact times were 1.5 ms.
Decoupling ﬁelds were 120 kHz.
DQCSA and fpRFDR-CT NMR measurements were performed on
Varian/Chemagnetics Inﬁnity spectrometers operating at proton NMR
frequencies of 400.6 MHz and 399.2 MHz, using Varian/Chemagnetics 3.2
mm MAS probes. DQCSA data were acquired as described by Blanco and
Tycko (2001), using an MAS frequency of 5.0 kHz, DQ preparation and
mixing periods of 6.4 ms, 13C p pulse lengths of 15.0 ms, and proton
decoupling ﬁelds of 110 kHz during the RFDR sequence in these periods.
DQ preparation and mixing periods were deliberately kept short to minimize
possible effects of intermolecular couplings on the DQCSA data. The
fpRFDR-CT data were acquired as described by Ishii et al. (2001), using an
MAS frequency of 20.0 kHz, 13C p pulse lengths of 10.0 ms and proton
decoupling ﬁelds of 110 kHz during the fpRFDR sequence, and with the
parameters K¼ 3 andM1 2N¼ 96, in the notation of Ishii et al. Pulsed spin
locking was used to enhance sensitivity in both fpRFDR-CT and DQCSA
measurements, as described by Petkova and Tycko (2002). Two-di-
mensional MAS exchange measurements were performed on a Chemag-
netics CMX spectrometer operating at a proton NMR frequency of 599.1
MHz, using the 2.5-mmMAS probe. Two-dimensional MAS exchange data
were acquired as described by Weliky and Tycko (Tycko et al., 1996;
Weliky and Tycko, 1996), using an MAS frequency of 3.78 kHz and 500-ms
exchange periods. These data were processed in the manner of Hagemeyer
et al. (Hagemeyer et al., 1989; Tycko and Berger, 1999). Radio-frequency
pulses were actively synchronized with an MAS tachometer signal in
fpRFDR-CT, DQCSA, and 2D MAS exchange measurements. Total
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experiment times were typically 8 h, 20 h, and 8 days for fpRFDR-CT,
DQCSA, and 2D MAS exchange measurements, respectively.
NMR data analysis
DQCSA, fpRFDR-CT, and 2D MAS exchange data were analyzed by
comparison with numerical simulations, performed with Fortran programs
written speciﬁcally for this purpose (Tycko et al., 1996; Blanco and Tycko,
2001). Simulations of fpRFDR-CT data were carried out for a four-spin
system (two carbonyl labels on two parallel chains), using an explicit
evaluation of the quantum mechanical evolution operator for the full pulse
sequence under MAS and including typical carbonyl CSA parameters as
well as all dipole-dipole couplings. Four-spin fpRFDR-CT simulations for
a full 58 grid in f and c with 864 powder orientations required ;110 h of
processor time (Pentium III, 1 GHz). Six-spin simulations (three carbonyl
labels on three parallel chains) were approximately six times slower and
produced fpRFDR-CT curves that were not signiﬁcantly different. Sim-
ulations of DQCSA and 2D MAS exchange data were carried out for
a two-spin system (two carbonyl labels on one chain). DQCSA simulations
also used an explicit evaluation of the evolution operator for the full pulse
sequence under MAS. Two-dimensional MAS exchange simulations used
numerical evaluations of integral expressions for the crosspeak intensities
(Tycko et al., 1996; Tycko and Berger, 1999). Effects of intermolecular
couplings on 2D MAS exchange and DQCSA data were ignored for the
following reasons: 1), 2D MAS exchange data are sensitive only to the
relative orientations, and not the displacements, of the labeled carbonyl
groups. Crosspeaks arise only from exchange between sites with different
orientations. Assuming that each peptide chain is labeled at a site A and a site
B and that neighboring chains in the cross-b amyloid ﬁbril structure are
related by translational symmetry along the ﬁbril axis, then exchange
between sites A or sites B of neighboring chains generates no crosspeak
intensity, whereas exchange between site A of one chain and site B of
a neighboring chain generates the same crosspeak intensities as intra-
molecular exchange; 2), DQCSA data depend on the excitation of DQ
coherences between carbonyl labels by an RFDR sequence (Gullion and
Vega, 1992; Bennett et al., 1998a). The RFDR sequence only recouples two
13C sites under MAS if they have different isotropic shifts or different
CSA tensor orientations. Again assuming translational symmetry, no DQ
coherence can be directly excited between sites A or sites B of neighboring
chains. Although DQ coherences can be excited between site A of one chain
and site B of a neighboring chain, numerical four-spin simulations show that
the contributions of such coherences to DQCSA signals are negligible under
the conditions of our experiments.
In all simulations, a standard carbonyl 13C chemical shift anisotropy
(CSA) tensor orientation was assumed, with the d33 axis perpendicular to the
carbonyl plane and the d22 axis at 1308 to the peptide C-N bond, as supported
by experimental (Oas et al., 1987; Teng et al., 1992; Asakura et al., 1998)
and ab initio quantum chemical (Walling et al., 1997) studies. CSA principal
values were determined experimentally for each doubly labeled sample (see
below).
The x2 deviation plotted in Fig. 4 has the general form:
x
2ðf;cÞ[ 1
s
2
rms1s
2
sim
+
N
i¼1
½Eil1ðf;cÞSiðf;cÞl2ðf;cÞ2;
where fEig are the experimental data values, fSi(f,c)g are the simulated
values for the given torsion angles, N is the number of values, srms is
uncertainty in the experimental data due to the root-mean-squared noise in
the experimental spectra, and ssim is uncertainty in the simulations. For
DQCSA and 2DMAS exchange simulations, ssim was taken to be negligible
compared with srms. For fpRFDR-CT simulations, ssim was taken to be 5%
of the maximum experimental data value, reﬂecting the high signal-to-noise
of the experimental spectra and uncertainty about effects of intermolecular
couplings beyond the four spins included in these simulations. l1(f,c) is
a scaling factor calculated to minimize x2 for the given torsion angles,
required because the intensity of the NMR signals is not measured on an
absolute scale (Tycko et al., 1996). l2(f,c) is an offset parameter, also
calculated to minimize x2, that was included only in fpRFDR-CT analyses to
account for contributions of natural-abundance 13C nuclei and residual
unﬁbrillized Ab1-40 to the data. Good agreement between simulations and
experiments corresponds to the condition x2 ; N.
RESULTS
One-dimensional 13C NMR spectroscopy
Fig. 1 shows 1D 13C MAS NMR spectra of the ﬁve doubly
labeled Ab1-40 ﬁbril samples. As previously demonstrated
(Antzutkin et al., 2000; Antzutkin et al., 2002; Balbach et al.,
2002), nearly complete ﬁbrillization of Ab1-40 is indicated by
the relative sharpness of the natural-abundance aliphatic 13C
FIGURE 1 Solid-state 13C NMR spectra of Ab1-40 ﬁbril samples with
13C
labels at the backbone carbonyl sites of the indicated residues, obtained with
MAS, cross polarization from protons, and high-power proton decoupling.
Spectra on the left were obtained at a 3.75-kHz MAS frequency. Strong
spinning sidebands between 90 ppm and 250 ppm for the carbonyl signals
indicate a rigid peptide backbone. Signals between 10 ppm and 60 ppm arise
from natural-abundance aliphatic 13C nuclei. Spectra on the right, showing
only the carbonyl region, were obtained at a 15-kHz MAS frequency.
Asterisk in the D23,V24-Ab1-40 spectrum indicates a labeled side-chain
carboxylate signal from a b-aspartate impurity at residue 23 (see Materials
and Methods).
3328 Antzutkin et al.
Biophysical Journal 84(5) 3326–3335
NMR signals (10–60 ppm spectral region), especially the
pronounced splitting of the a-carbon signals into peaks at
52 ppm and 58 ppm. Two-dimensional 13C-13C exchange
spectra of Ab1-40 samples with uniformly labeled residues
(Petkova et al., 2002) indicate that the peak at 58 ppm arises
from the a-carbon signals of valine and isoleucine residues,
which converge to this NMR frequency when b-strands form
concomitantly with ﬁbrillization.
Spectra at MAS frequency nR¼ 3.75 kHz (left side of Fig.
1) show the spinning sideband patterns expected for carbonyl
13C labels. CSA principal values determined from these
spectra (Herzfeld and Berger, 1980) are given in Table 1.
CSA principal values in Table 1 represent average values for
the two labels in each sample except in the case of V24,G25-
Ab1-40, where signals from the two labels could be
deconvolved to permit determination of the principal values
of the individual sites. All CSA values are consistent with the
absence of large-amplitude motions of the carbonyl groups,
i.e., a rigid peptide backbone.
Signiﬁcant variations in the carbonyl 13C lineshapes are
observed (right side of Fig. 1). Due to overlap, it is not
possible to extract the lineshape for each individual 13C-
labeled site from these spectra. Certain sites (e.g., the A30
carbonyl) apparently have 13C NMR linewidths of ;1.5
ppm, whereas other sites (especially the G25 and G29
carbonyls) have larger linewidths or exhibit multiple,
partially resolved lines. These lineshapes appear to indicate
a mixture of local structural uniformity at some sites and
structural heterogeneity at other sites in the segment from
D23 through A30. For comparison, carbonyl 13C NMR
linewidths for V12, L17, F20, V24, L34, and V39 in Ab1-40
ﬁbril samples with single 13C labels have been found to be
1.3–3.0 ppm, with both F20 and L34 exhibiting two partially
resolved carbonyl lines in 13C MAS spectra (Balbach et al.,
2002). We associate the observation of multiple 13C NMR
lines for single sites with the observation of multiple ﬁbril
morphologies in typical amyloid ﬁbril preparations (Golds-
bury et al., 2000; Jimenez et al., 2002). The degree of
structural heterogeneity at the molecular level, especially the
ranges of f and c values, can not be determined in
quantitative terms from these data.
Qualitative interpretation of structural data
As depicted in Fig. 2, 13C-labeling of two consecutive
backbone carbonyl sites, at residues i-1 and i, permits the
acquisition of solid-state NMR data that place constraints on
the f and c torsion angles of residue i. The fpRFDR-CT
technique measures the 13C-13C magnetic dipole-dipole
coupling, which depends on the 13C-13C distance and
therefore on the f angle. The DQCSA and 2D MAS
exchange techniques measure the relative orientation of
the two 13C CSA tensors, which depends on the relative
orientation of the carbonyl groups and therefore on both f
and c. For all residues in any b-strand, the f and c values
are approximately 1408 6 208 and 1408 6 208, re-
spectively. Because of the uniformity of the f and c values
in a b-strand, if one prepares a series of doubly carbonyl-
labeled peptide samples with 13C labels in a b-strand
segment, one expects all samples in the series to yield nearly
the same fpRFDR-CT, DQCSA, and 2D MAS exchange
data. At a qualitative level, signiﬁcant differences in these
data from different samples would indicate a non-b-strand
conformation.
Fig. 3, a and b, present fpRFDR-CT and DQCSA data for
the ﬁve doubly labeled Ab1-40 ﬁbril samples described
above. Signiﬁcant differences in the data from different
samples are indeed observed, indicating that the f and c
values in the segment from D23 through A30 are not uniform
in Ab1-40 ﬁbrils. In fpRFDR-CT measurements, one records
the decay of the 13C NMR signal from the labeled sites with
TABLE 1 Chemical shift anisotropy parameters for 13C-labeled
carbonyl carbons in Ab1-40 ﬁbrils, determined from analyses of
spinning sideband intensities in spectra as in Fig. 1
Sample d (ppm) h
D23,V24-Ab1-40 80.4 0.68
V24,G25-Ab1-40 (V24 carbonyl) 86.9 0.70
V24,G25-Ab1-40 (G25 carbonyl) 78.3 0.80
G25,S26-Ab1-40 78.4 0.77
K28,G29-Ab1-40 79.3 0.85
G29,A30-Ab1-40 79.2 0.75
Except in the case of V24,G25-Ab1-40, values are averages for two labeled
sites with unresolved 13C NMR signals. d[ diso  d33 and h[ ðd11  d22Þ=
ðdiso  d33Þ, where d11, d22, and d33 are the principal values of the chemical
shift anisotropy tensor and diso[ ðd11 1 d221 d33Þ=3:Uncertainties in d and
h are approximately64%.
FIGURE 2 Illustration of the use of double carbonyl 13C labeling to
determine polypeptide backbone torsion angles f and c. A segment of
a polyalanine chain is shown, with labeled sites in green. Directions of the
principal axes of the carbonyl CSA tensors are shown. The d33 principal axis
is perpendicular to the d11 and d22 axes. The fpRFDR-CT solid-state NMR
technique primarily measures the 13C-13C distance, which depends on f.
The DQCSA and 2D MAS exchange techniques measure the relative
orientation of the two CSA tensors, which depends on both f and c.
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increasing dipolar dephasing time tD, due to the
13C-13C
dipole-dipole couplings (Ishii et al., 2001). A more rapid
decay indicates a shorter 13C-13C distance, implying a small-
er value of jfj. In Fig. 3 a, the most rapid fpRFDR-CT decay
is observed for V24,G25-Ab1-40 ﬁbrils, whereas the slow-
est decays are observed for D23,V24-Ab1-40 ﬁbrils and
G29,A30-Ab1-40 ﬁbrils. In DQCSA measurements, one
records the decay of the double-quantum ﬁltered 13C NMR
signal with increasing CSA evolution time tCSA. The decay
rate of DQCSA signals depends on f and c in a complicated
manner (Blanco and Tycko, 2001). According to simula-
tions, the slowest DQCSA decays occur near f ¼ 608 and
c ¼ 658 (or f ¼ 608 and c ¼ 658). The most rapid decays
occur near f¼61808 or 08 and c¼61808 or 08. In Fig. 3 b,
the slowest DQCSA decay is observed for V24,G25-Ab1-40
ﬁbrils, whereas the most rapid decay is observed for
G29,A30-Ab1-40 ﬁbrils.
Fig. 3, c and d, show 2D MAS exchange spectra for the
G25,S26-Ab1-40 and G29,A30-Ab1-40 ﬁbril samples. In
these spectra, the intensities of crosspeaks that connect
FIGURE 3 (a ) Expe r imen t a l
fpRFDR-CT data for the ﬁve doubly
labeled Ab1-40 ﬁbril samples. Curves
are simulations for jfj between 408
and 1658, in 258 increments. (b) Ex-
perimental DQCSA data. Color-coded
curves are simulations for the f and c
values in Table 2. (c and d) Experi-
mental 2D MAS exchange spectra for
two of the samples, represented as
contour plots with contour levels
increasing by factors of 1.6. Cross-
peaks connecting MAS sidebands are
numbered. (e) Crosspeak volumes
from the 2D MAS exchange spectra,
after symmetrization, normalized to
the volume of the strongest crosspeak.
The signiﬁcant differences among
fpRFDR-CT data, DQCSA data, and
2D MAS exchange data for different
samples indicate signiﬁcant variations
in the f and c values, demonstrating
the presence of non-b-strand confor-
mations at certain sites in the segment
from D23 to A30.
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spinning sideband signals of the two labeled carbonyl sites
are complicated functions of both f and c (Tycko et al.,
1996; Tycko and Berger, 1999). Signiﬁcant differences in
crosspeak intensities for these two samples are apparent,
with greater intensity in crosspeaks further from the diagonal
in the case of G25,S26-Ab1-40 ﬁbrils.
Quantitative analysis of structural data
We analyze the fpRFDR-CT, DQCSA, and 2D MAS
exchange data by simulating the data for all possible f,c
pairs (in 58 increments) and plotting the dependence of the x2
deviation between experimental data and simulations on f
and c. As previously demonstrated for DQCSA and 2D
MAS measurements on model peptides of known structure
(Tycko et al., 1996; Weliky and Tycko, 1996; Blanco and
Tycko, 2001), these simulations are sufﬁciently accurate that
the absolute minimum value xmin
2 occurs within 6108 of the
correct f and c values. In x2 plots for DQCSA and 2D MAS
exchange data, additional local minima xloc
2 are typically
observed at other f and c values where the simulated data
are similar to data for the correct f and c values. When xmin
2
 xloc2 , for example due to insufﬁcient signal-to-noise in the
experiments, the correct f and c values can be determined
by combining the results of independent techniques, which
may then exhibit only a single common x2 minimum at the
correct values (Bennett et al., 1998b; Weliky et al., 1999;
Balbach et al., 2000).
Representative x2 contour plots, for G25,S26-Ab1-40
ﬁbrils and G29,A30-Ab1-40 ﬁbrils, are shown in Fig. 4.
Ideally, the best-ﬁt (i.e., minimum x2) regions in the contour
plots for fpRFDR-CT, DQCSA, and 2D MAS exchange data
for a given sample would overlap in a single small area of the
f,c plane, which would then indicate the correct values of f
and c. As can be seen in Fig. 4, precise overlap of the best-ﬁt
regions for the DQCSA and 2D MAS exchange data is not
observed. We attribute the absence of precise overlap to two
factors: 1), Conformational heterogeneity in the non-b-
strand segment of ﬁbrillized Ab1-40, as suggested by the
relatively broad carbonyl 13C NMR lines for G25 and G29
discussed above. If a distribution of f and c values were
signiﬁcantly populated, one would expect xmin
2 for different
techniques to shift in different directions, reducing or
possibly eliminating the overlap; 2), Necessary approxima-
tions in the simulations, including the use of average CSA
principal values for carbonyl 13C pairs with unresolved
NMR signals, the assumption of a standard CSA tensor
orientation for all carbonyl sites, and the neglect of inter-
molecular 13C-13C couplings (see Materials and Methods).
Again, one would expect these approximations to produce
different shifts in xmin
2 for different techniques.
To extract estimates of f and c from the x2 contour plots,
the following procedure was therefore adopted: 1), A range
of allowed f values was determined from the fpRFDR-CT
contour plot, given by the condition x2\ 10; 2), The x2
minima in the DQCSA and 2D MAS exchange contour plots
that lie within this f range and were closest together in the
f,c plane were identiﬁed; 3), The average of the f and c
values at these two minima was taken as an estimate of the
correct values. Estimates of f and c determined with this
procedure are summarized in Table 2. Backbone torsion
angles for G25, S26, and G29 are found to be signiﬁcantly
different from b-strand values, whereas torsion angles for
V24 and A30 are consistent with a b-strand conformation.
These results are sensible in light of evidence from 13C NMR
chemical shifts for b-strand segments formed by residues 12-
24 and 30-36 (Petkova et al., 2002). Uncertainty in f and c
due to conformational heterogeneity, suggested by the 1D
13C NMR spectra as discussed above, cannot be determined
quantitatively from the data obtained to date.
FIGURE 4 Contour plots of the x2 deviation between experimental data
and simulations for two of the doubly labeled Ab1-40 ﬁbril samples (see
Materials and Methods for precise deﬁnition of x2). For fpRFDR-CT
measurements, dark blue regions indicate x2\ 5, white regions indicate x2
[ 25, and contour levels increase in units of 5. For DQCSA measurements,
dark blue regions indicate x2\ 70, white regions indicate x2[ 150, and
contour levels increase in units of 20. For 2DMAS exchange measurements,
dark blue regions indicate x2\ 40, white regions indicate x2[ 120, and
contour levels increase in units of 20. White stars indicate the estimated f
and c values for S26 (left side) and A30 (right side), obtained from
a consensus ﬁt to the three measurements (see text).
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For reasons of symmetry (Tycko et al., 1996), fpRFDR-
CT, DQCSA, and 2D MAS exchange data are invariant
to the substitution f;c! f;c. Therefore, x2ðf;cÞ ¼
x2ðf;cÞ and only negative values of f are plotted in
Fig. 4. For V24 and A30, the choice of signs for f and c in
Table 2 is appropriate for a b-strand conformation. For G25,
S26, and G29, the sign choices in Table 2 were selected after
molecular modeling (see below). Solid-state NMR data in
this paper do not rule out the opposite sign choices for G25,
S26, and G29.
DISCUSSION
Molecular modeling
The data reported above do not permit a unique de-
termination of the backbone structure of residues 24-30 in
Ab1-40 ﬁbrils, both because the signs of f and c are in-
determinate and because these data do not constrain f and c
of N27 and K28. To permit visualization of the structural
consequences of the non-b-strand conformations at G25,
S26, and G29, Fig. 5 shows structural models for residues
20-33, assuming typical b-strand f and c values for residues
20-23, 27, 28, and 31-33. 13C chemical shift data support a
b-strandconformationatK28(Petkovaetal.,2002).Values for
V24, G25, S26, G29, and A30 are taken from Table 2. Eight
models are shown, generated with all possible sign choices
for f and c of G25, S26, and G29. No energy minimization
or other optimization of these models was performed.
Although all models in Fig. 5 are equally consistent with
data in this paper, they are not all consistent with constraints
imposed by supramolecular structure. 13C chemical shift data
have established that the segments ﬂanking residues 24-30
form b-strands in Ab1-40 ﬁbrils (Petkova et al., 2002).
Multiple quantum 13C NMR (Antzutkin et al., 2000) and
13C-13C dipolar recoupling data (Balbach et al., 2002) have
established that these two b-strands form separate parallel
b-sheets through intermolecular hydrogen bonding. To be
compatible with a cross-b ﬁbril structure, the two b-strands
must be aligned so that all intermolecular hydrogen bonds
are nearly parallel to a single axis (namely, the long axis of
the ﬁbril). Thus, all backbone carbonyl C-O bonds and amide
N-H bonds in the b-strands must be nearly parallel to one
another. Only the models in Fig. 5, a and h, satisfy this
requirement. Of these two, only the model in Fig. 5 a
produces the net bend in the direction of the peptide
backbone required by the experimentally observed diameters
of Ab1-40 ﬁbrils (see Introduction). For these reasons, the
conformation in Fig. 5 a was used as a starting point for the
recent development of a full structural model for Ab1-40
ﬁbrils by constrained energy minimization (Petkova et al.,
2002). In addition, the backbone conformation in Fig. 5 a
permits close contacts between the side-chain carboxylate
and amino groups of D23 and K28, as supported by ex-
perimental measurements of 15N-13C dipole-dipole cou-
plings that indicate internuclear distances on the order of 0.4
nm for these groups (Petkova et al., 2002).
TABLE 2 Backbone torsion angles (degrees) in Ab1-40 ﬁbrils,
estimated from solid-state NMR data on doubly labeled
samples as described in the text
Residue f,c
V24 145,115
G25 70,40
S26 68,65
G29 120,125
A30 165,133
Data are invariant to the substitution f;c!  f;c: Choice of signs here
corresponds to the model in Fig. 5 a.
FIGURE 5 Possible conformations for residues 20-33 of Ab1-40 in
amyloid ﬁbrils, based on the f and c values for V24, G25, S26, G29, and
A30 estimated from solid-state NMR measurements. Typical b-strand
values (f ¼ 1408, c ¼ 1408) are assigned to all other residues. The eight
models represent all possible sign choices for f and c of the non-b-strand
residues G25, S26, and G29, given that the NMR data are invariant to the
substitution f;c! f;c: Only nonhydrogen atoms are shown. Side
chains of residues 20–22 and 31–33 are omitted for clarity. To facilitate
comparison, all models are shown with residues 20–24 at the same ori-
entation. Side-chain conformations are not constrained by the data. (a)
Conformation resulting from the values and sign choices in Table 2. (b) Sign
reversal for G25. (c) Sign reversal for S26. (d) Sign reversal for G25 and
S26. (e) Sign reversal for G29. ( f ) Sign reversal for G25 and G29. (g) Sign
reversal for S26 and G29. (h) Sign reversal for G25, S26, and G29. (Figure
created with MOLMOL (Koradi et al., 1996))
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Comparison with earlier structural models
Several models for full-length Ab ﬁbrils have included a b-
hairpin with a turn in residues 25-28 (George and Howlett,
1999; Li et al., 1999) or 24-27 (Lazo and Downing, 1998). A
true b-hairpin requires intramolecular hydrogen bonding
between b-strands that ﬂank the turn. However, 13C-13C
dipolar recoupling data indicate intermolecular distances of
0.48 6 0.05 nm (as required by intermolecular hydrogen
bonding) between carbonyl or b-carbon sites of V12, L17,
F20, A21, V24, A30, L34, and V39 in Ab1-40 ﬁbrils
(Balbach et al., 2002). Multiple quantum 13C NMR data have
shown that the b-carbons of both A21 and A30 must form
groups of at least four with interatomic distances of;0.5 nm
(Antzutkin et al., 2000). These data rule out a true b-hairpin
with intramolecular hydrogen bonding. Thus, we believe that
the non-b-strand conformations in residues 24-30 simply
create a bend or hinge between two separate parallel b-sheets
in Ab1-40 ﬁbrils (Petkova et al., 2002), reminiscent of the
bends between b-strands in b-helical proteins (Yoder et al.,
1993; Emsley et al., 1996) (although our data do not imply
that Ab ﬁbrils necessarily have the b-helical structure
suggested for amyloid ﬁbrils by other groups (Lazo and
Downing, 1998; Perutz et al., 2002; Wille et al., 2002)). A
similar structural role for these residues occurs in Ab ﬁbril
models proposed by Tjernberg et al. (1999) and by Ma and
Nussinov (2002).
Concluding remarks
One might expect the presence of a non-b-strand segment in
the middle of the Ab1-40 sequence to have implications for
the effects of amino acid substitutions on ﬁbril structure or
stability. Although a number of mutagenesis studies have
been reported, most of these deal with effects of substitutions
outside the region addressed by our measurements (Fraser
et al., 1992; Hilbich et al., 1992; Pike et al., 1995; Esler et al.,
1996; Murakami et al., 2002) or with amyloid ﬁbrils formed
by Ab fragments that may not be representative of the full-
length peptide (Kirschner et al., 1987; Fraser et al., 1994;
Wood et al., 1995). A recent study by Morimoto et al. (2002)
has shown that substitutions of proline at residues 24 and 26
in Ab1-42 suppress aggregation and ﬁbrillization, consistent
with the fact that proline cannot adopt the f and c angles
given for V24 and S26 in Table 2. Mutations associated with
familial Alzheimer’s disease, including A21G, E22Q, E22K,
E22G, and D23N, occur near the non-b-strand segment
identiﬁed by our measurements. It is not yet clear whether
kinetic, structural, thermodynamic, or purely biological
factors lead to the association of these mutations with
genetic predisposition to Alzheimer’s disease.
Finally, the solid-state NMR data reported above dem-
onstrate in a quantitative and site-speciﬁc manner that
amyloid ﬁbrils have structural complexity at the molecular
level beyond the simple requirement of a cross-b motif.
Determination of the full molecular structures of amyloid
ﬁbrils entirely from experimental data remains an important
and difﬁcult challenge. Nonetheless, we believe that this
challenge can be met through a combination of solid-state
NMR measurements that probe supramolecular organiza-
tion, identify b-strand segments, characterize the conforma-
tion of non-b-strand segments, and establish intermolecular
and intramolecular contacts, with assistance from EM and
other physical techniques.
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